STOCKHOLDERS' EQUITY

9 Months Ended

Oct. 30, 2022

Equity [Abstract]

Stockholders' Equity

STOCKHOLDERS' EQUITY

Stock Rollforward

The following table presents a reconciliation of the number of shares of our common stock outstanding and cash dividends per share:

shares in millions	Three Months Ended				Nine Months Ended
	October 30, 2022		October 31, 2021		October 30, 2022		October 31, 2021
Common stock:
Balance at beginning of period	1,793		1,791		1,792		1,789
Shares issued under employee stock plans	—		—		1		2
Balance at end of period	1,793		1,791		1,793		1,791
Treasury stock:
Balance at beginning of period	(769)		(735)		(757)		(712)
Repurchases of common stock	(4)		(10)		(16)		(33)
Balance at end of period	(773)		(745)		(773)		(745)
Shares outstanding at end of period	1,020		1,046		1,020		1,046
Cash dividends per share	$	1.90	$	1.65	$	5.70	$	4.95

Share Repurchases

In August 2022, our Board of Directors approved a $15.0 billion share repurchase authorization that replaced the previous authorization of $20.0 billion, which was approved in May 2021. This new authorization does not have a prescribed expiration date. As of October 30, 2022, $14.0 billion of the $15.0 billion share repurchase authorization remained available.

The following table presents information about our repurchases of common stock, all of which were completed through open market purchases:

in millions	Three Months Ended				Nine Months Ended
	October 30, 2022		October 31, 2021		October 30, 2022		October 31, 2021
Total number of shares repurchased	4		10		16		33
Total cost of shares repurchased	$	1,224	$	3,500	$	4,994	$	10,500

These amounts may differ from the repurchases of common stock amounts in the consolidated statements of cash flows due to unsettled share repurchases at the end of a period.